首页> 外国专利> USE OF HYPOTHALAMIC INHIBITORY FACTOR IN THE TREATMENT OF ISCHEMIC CARDIAC MALFUNCTION

USE OF HYPOTHALAMIC INHIBITORY FACTOR IN THE TREATMENT OF ISCHEMIC CARDIAC MALFUNCTION

机译:下丘脑抑制因子在缺血性心功能不全治疗中的应用

摘要

The present invention is based on the unexpected discoveries that hypothalamic inhibitory factor (HIF) has a positive inotropic effect in a whole organ preparation, such as an isolated perfused heart, and that HIF, to a greater extent than ouabain, dilates the coronary arteries in the isolated perfused heart as manifested in increased coronary flow in hearts treated with HIP. The present invention relates to a method for increasing coronary perfusion in a mammalian host comprising administering to the host in need thereof an effective amount of hypothalamic inhibitory factor (HIF). The invention also relates to a method for producing an increased coronary vasodilatory effect in a mammalian host comprising administering to a mammalian host in need thereof an effective amount of HIF. The method of the present invention can be used to prevent and/or treat ischemic cardiac malfunction and coronary artery restenosis.
机译:本发明基于意想不到的发现,即下丘脑抑制因子(HIF)在整个器官制剂例如离体的灌注心脏中具有正性肌力作用,并且该HIF比哇巴因更大程度地扩张了冠状动脉中的冠状动脉。分离的灌注心脏表现为接受HIP治疗的心脏冠脉流量增加。本发明涉及一种在哺乳动物宿主中增加冠状动脉灌注的方法,该方法包括对有需要的宿主给予有效量的下丘脑抑制因子(HIF)。本发明还涉及一种在哺乳动物宿主中产生增加的冠状血管舒张作用的方法,该方法包括向需要其的哺乳动物宿主施用有效量的HIF。本发明的方法可以用于预防和/或治疗缺血性心脏功能障碍和冠状动脉再狭窄。

著录项

  • 公开/公告号EP0983071B1

    专利类型

  • 公开/公告日2004-10-20

    原文格式PDF

  • 申请/专利权人 THE GENERAL HOSPITAL CORPORATION;

    申请/专利号EP19980923838

  • 发明设计人 HAUPERT GARNER T. JR.;

    申请日1998-05-28

  • 分类号A61K31/704;A61P9/10;

  • 国家 EP

  • 入库时间 2022-08-21 22:57:36

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号